Company profile

Ticker
MRK
Exchange
CEO
Kenneth C. Frazier
Employees
Incorporated in
Location
Fiscal year end
Former names
Merck & Co. Inc., Schering Plough Corp
SEC CIK
IRS number
221918501

MRK stock data

(
)

Calendar

6 Aug 19
19 Aug 19
31 Dec 19

News

Company financial data Financial data

Quarter (USD) Jun 19 Mar 19 Dec 18 Sep 18
Revenue 11.76B 10.82B 11B 10.79B
Net income 2.67B 2.92B 1.83B 1.95B
Diluted EPS 1.03 1.12 0.69 0.73
Net profit margin 22.70% 26.95% 16.61% 18.07%
Net change in cash -1.42B 111M 139M 2.52B
Cash on hand 6.66B 8.08B 7.97B 7.83B
Cost of revenue 3.4B 3.05B 3.29B 3.62B
Annual (USD) Dec 18 Dec 17 Dec 16 Dec 15
Revenue 42.29B 40.12B 39.81B
Net income 6.22B 2.39B 3.92B 4.44B
Diluted EPS 2.32 0.87 1.41 1.56
Net profit margin 14.71% 5.97% 9.85%
Net change in cash 1.87B -423M -2.01B 1.08B
Cash on hand 7.97B 6.09B 6.52B 8.52B
Cost of revenue 13.51B 12.91B 14.03B 14.93B

Financial data from Merck & Co. earnings reports

Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: addressing, allegedly, amenable, analyzed, antibacterial, biopharmaceutical, broadened, central, CID, cilastatin, Civil, EHR, esophagogastric, frequency, Fusion, HAP, HIPAA, incorrectly, locoregional, manner, molecule, page, pathologic, pCR, Peloton, PFI, Portability, predominantly, protocol, Recarbrio, Shortly, similarly, subpoena, susceptible, tissue, unopposed, USAO, VAP, Vermont, VT, West
Removed: acetate, began, bench, caspofungin, cisplatin, covered, directed, distributing, entitled, expiry, expression, extensive, Fl, hold, improved, infringe, infringed, Italy, Kabi, partial, patient, promoting, reached, Roxane, ruminant, sell, Sterile, studied, USA, version